文献速递中毒与环境急症消化、代谢与肾脏急症

社区脆弱性与阿片类使用障碍药物可及性的评估

Assessment of Community-Level Vulnerability and Access to Medications for Opioid Use Disorder.
PubMed 文献 · JAMA Netw Open · 2022-04-01
一句话结论横断面研究显示,社会脆弱性更高的社区并未获得更好的阿片类使用障碍药物地理可及性,郊区不匹配最突出,农村可及性普遍差。

该横断面研究对美国本土32 434个邮政编码制表区(ZCTA)2020年治疗地点数据进行地理空间分析,以CDC社会脆弱性指数为暴露,以驾车时间(分钟)为结局,评估丁丙诺啡、美沙酮和缓释纳曲酮三类阿片类使用障碍药物的地理可及性。结果显示,社会脆弱性越高,美沙酮驾车时间越长(相关系数0.10,95%CI 0.09至0.11),与其他药物可及性无关;农村ZCTA中脆弱性越高丁丙诺啡驾车时间越短(相关系数-0.10,95%CI -0.12至-0.08);郊区ZCTA中脆弱性越高美沙酮(相关系数0.22,95%CI 0.20至0.24)和缓释纳曲酮(相关系数0.15,95%CI 0.13至0.17)驾车时间均越长。作者认为,社区脆弱性与药物可及性不匹配,郊区最明显,农村可及性普遍差,未来灾害准备规划应将服务地点与高脆弱性社区匹配,以防止过量死亡不平等。

要点

  • 社会脆弱性越高,美沙酮驾车时间越长(相关系数0.10,95%CI 0.09至0.11),丁丙诺啡和缓释纳曲酮可及性与脆弱性无关。
  • 郊区ZCTA中,脆弱性越高美沙酮(相关系数0.22,95%CI 0.20至0.24)和缓释纳曲酮(相关系数0.15,95%CI 0.13至0.17)驾车时间均越长。
  • 农村ZCTA中,脆弱性越高丁丙诺啡驾车时间越短(相关系数-0.10,95%CI -0.12至-0.08),其他可及性指标与脆弱性无关。
  • 农村社区无论脆弱性高低,地理可及性均差。
  • 作者认为,灾害准备规划应将服务地点与高脆弱性社区匹配,以防止过量死亡不平等。

适用人群与场景

  • 美国本土(不含华盛顿特区)的邮政编码制表区(ZCTA),最终纳入32 434个ZCTA。

研究设计与关键结果

  • 研究类型为横断面研究,对2020年治疗地点数据进行地理空间分析,最终样本为32 434个ZCTA(排除华盛顿特区170个ZCTA和20个无城乡分类的ZCTA)。
  • 社会脆弱性越高,美沙酮驾车时间越长(相关系数0.10,95%CI 0.09至0.11),但与丁丙诺啡和缓释纳曲酮可及性无关。
  • 农村ZCTA中,脆弱性越高丁丙诺啡驾车时间越短(相关系数-0.10,95%CI -0.12至-0.08),其他可及性指标与脆弱性无关。
  • 郊区ZCTA中,脆弱性越高美沙酮驾车时间越长(相关系数0.22,95%CI 0.20至0.24),缓释纳曲酮驾车时间也越长(相关系数0.15,95%CI 0.13至0.17)。
  • 作者结论:脆弱性更高的社区并未获得更好的阿片类使用障碍药物地理可及性,郊区不匹配最突出,农村社区无论脆弱性如何地理可及性均差。

证据类型、等级与局限

  • 证据类型:横断面研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,未来灾害准备规划应将服务地点与脆弱性更高的社区匹配,以防止过量死亡不平等。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Given that COVID-19 and recent natural disasters exacerbated the shortage of medication for opioid use disorder (MOUD) services and were associated with increased opioid overdose mortality, it is important to examine how a community's ability to respond to natural disasters and infectious disease outbreaks is associated with MOUD access.

OBJECTIVE: To examine the association of community vulnerability to disasters and pandemics with geographic access to each of the 3 MOUDs and whether this association differs by urban, suburban, or rural classification.

DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study of zip code tabulation areas (ZCTAs) in the continental United States excluding Washington, DC, conducted a geospatial analysis of 2020 treatment location data.

EXPOSURES: Social vulnerability index (US Centers for Disease Control and Prevention measure of vulnerability to disasters or pandemics).

MAIN OUTCOMES AND MEASURES: Drive time in minutes from the population-weighted center of the ZCTA to the ZCTA of the nearest treatment location for each treatment type (buprenorphine, methadone, and extended-release naltrexone).

RESULTS: Among 32 604 ZCTAs within the continental US, 170 within Washington, DC, and 20 without an urban-rural classification were excluded, resulting in a final sample of 32 434 ZCTAs. Greater social vulnerability was correlated with longer drive times for methadone (correlation, 0.10; 95% CI, 0.09 to 0.11), but it was not correlated with access to other MOUDs. Among rural ZCTAs, increasing social vulnerability was correlated with shorter drive times to buprenorphine (correlation, -0.10; 95% CI, -0.12 to -0.08) but vulnerability was not correlated with other measures of access. Among suburban ZCTAs, greater vulnerability was correlated with both longer drive times to methadone (correlation, 0.22; 95% CI, 0.20 to 0.24) and extended-release naltrexone (correlation, 0.15; 95% CI, 0.13 to 0.17).

CONCLUSIONS AND RELEVANCE: In this study, communities with greater vulnerability did not have greater geographic access to MOUD, and the mismatch between vulnerability and medication access was greatest in suburban communities. Rural communities had poor geographic access regardless of vulnerability status. Future disaster preparedness planning should match the location of services to communities with greater vulnerability to prevent inequities in overdose deaths.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Joudrey PJ, Kolak M, Lin Q, et al. Assessment of Community-Level Vulnerability and Access to Medications for Opioid Use Disorder. JAMA Netw Open. 2022. PMID: 35438757. doi:10.1001/jamanetworkopen.2022.7028

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。